ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
BARX2 | BARX homeobox 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
C1orf116 | Chromosome 1 open reading frame 116 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C6orf132 | Chromosome 6 open reading frame 132 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CD1A | CD1a molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CLCA2 | Chloride channel accessory 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DSC2 | Desmocollin 2 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FUT3 | Fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) | Blood group antigen proteins Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GRHL1 | Grainyhead-like 1 (Drosophila) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HIST1H2BF | Histone cluster 1, H2bf | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H4D | Histone cluster 1, H4d | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
IL1RN | Interleukin 1 receptor antagonist | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IVL | Involucrin | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
KLK10 | Kallikrein-related peptidase 10 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
KRT24 | Keratin 24 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MYH11 | Myosin, heavy chain 11, smooth muscle | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MYH8 | Myosin, heavy chain 8, skeletal muscle, perinatal | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
NIPAL1 | NIPA-like domain containing 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
NKX6-1 | NK6 homeobox 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PKP3 | Plakophilin 3 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
RHOV | Ras homolog family member V | Predicted intracellular proteins
| | | | | Tissue enhanced |
RNASE7 | Ribonuclease, RNase A family, 7 | Predicted secreted proteins
| | | | | Tissue enhanced |
S100A2 | S100 calcium binding protein A2 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
SAMD9 | Sterile alpha motif domain containing 9 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SCEL | Sciellin | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SERPINB2 | Serpin peptidase inhibitor, clade B (ovalbumin), member 2 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SLC6A11 | Solute carrier family 6 (neurotransmitter transporter), member 11 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
TACSTD2 | Tumor-associated calcium signal transducer 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
TP63 | Tumor protein p63 | Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
USH1G | Usher syndrome 1G (autosomal recessive) | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |